erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Tuberculosis D014376 20 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Otitis Media D010033 12 associated lipids
Adenocarcinoma D000230 166 associated lipids
Bacterial Infections D001424 21 associated lipids
Otitis Externa D010032 8 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Stomach Diseases D013272 7 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Skin Neoplasms D012878 12 associated lipids
Pleurisy D010998 20 associated lipids
Inflammation D007249 119 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Genital Diseases, Male D005832 3 associated lipids
Sexually Transmitted Diseases D012749 4 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Bone Resorption D001862 7 associated lipids
Arthritis D001168 41 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Abscess D000038 13 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Heart Failure D006333 36 associated lipids
Osteitis D010000 10 associated lipids
Osteomyelitis D010019 10 associated lipids
Liver Diseases D008107 31 associated lipids
Corneal Diseases D003316 13 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Hypersensitivity D006967 22 associated lipids
Acne Vulgaris D000152 35 associated lipids
Osteolysis D010014 8 associated lipids
Rhinitis D012220 10 associated lipids
Skin Ulcer D012883 6 associated lipids
Heart Diseases D006331 8 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Multiple Myeloma D009101 13 associated lipids
Quadriplegia D011782 4 associated lipids
Pain, Postoperative D010149 13 associated lipids
Porphyrias D011164 2 associated lipids
Femoral Fractures D005264 7 associated lipids
Hematuria D006417 13 associated lipids
Labyrinth Diseases D007759 3 associated lipids
Weight Gain D015430 101 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Abnormalities, Drug-Induced D000014 10 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Endocarditis, Bacterial D004697 5 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Obesity D009765 29 associated lipids
Bradycardia D001919 13 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Intraoperative Complications D007431 5 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Eye Diseases D005128 12 associated lipids
Salpingitis D012488 2 associated lipids
Leukemia D007938 74 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Fractures, Open D005597 3 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Crohn Disease D003424 12 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Cholestasis D002779 23 associated lipids
Sinusitis D012852 9 associated lipids
Glomerulonephritis D005921 35 associated lipids
Sepsis D018805 11 associated lipids
Nervous System Diseases D009422 37 associated lipids
Enterocolitis, Pseudomembranous D004761 8 associated lipids
Ataxia D001259 20 associated lipids
Psoriasis D011565 47 associated lipids
Urinary Tract Infections D014552 11 associated lipids
Cross Infection D003428 9 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Wound Infection D014946 12 associated lipids
Bacteriuria D001437 7 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Derrouiche S et al. Process design for wastewater treatment: catalytic ozonation of organic pollutants. 2013 Water Sci. Technol. pmid:24056437
Avella AC et al. Activated sludge behaviour in a batch reactor in the presence of antibiotics: study of extracellular polymeric substances. 2010 Water Sci. Technol. pmid:20555211
Aydın S et al. Inhibitory effect of erythromycin, tetracycline and sulfamethoxazole antibiotics on anaerobic treatment of a pharmaceutical wastewater. 2015 Water Sci. Technol. pmid:26038926
Aydin S et al. Performance of anaerobic sequencing batch reactor in the treatment of pharmaceutical wastewater containing erythromycin and sulfamethoxazole mixture. 2014 Water Sci. Technol. pmid:25429450
Aydin S et al. Development of antibiotic resistance genes in microbial communities during long-term operation of anaerobic reactors in the treatment of pharmaceutical wastewater. 2015 Water Res. pmid:26188597
Aydin S et al. Application of real-time PCR to determination of combined effect of antibiotics on Bacteria, Methanogenic Archaea, Archaea in anaerobic sequencing batch reactors. 2015 Water Res. pmid:25792437
Wunder DB et al. Sorption of antibiotics to biofilm. 2011 Water Res. pmid:21334040
González-Pleiter M et al. Toxicity of five antibiotics and their mixtures towards photosynthetic aquatic organisms: implications for environmental risk assessment. 2013 Water Res. pmid:23399078
Subirats J et al. Emerging contaminants and nutrients synergistically affect the spread of class 1 integron-integrase (intI1) and sul1 genes within stable streambed bacterial communities. 2018 Water Res. pmid:29573631
Fan C and He J Proliferation of antibiotic resistance genes in microbial consortia of sequencing batch reactors (SBRs) upon exposure to trace erythromycin or erythromycin-H2O. 2011 Water Res. pmid:21482429
Michael-Kordatou I et al. Erythromycin oxidation and ERY-resistant Escherichia coli inactivation in urban wastewater by sulfate radical-based oxidation process under UV-C irradiation. 2015 Water Res. pmid:26360228
Luiz DB et al. Identification of degradation products of erythromycin A arising from ozone and advanced oxidation process treatment. 2010 Sep-Oct Water Environ. Res. pmid:20942335
Ponte CD et al. Pseudomembranous colitis: a case report and literature review. 1984 W V Med J pmid:6380115
Khakoo R Mycoplasma pneumoniae infections. 1981 W V Med J pmid:6243022
BoÄ­ko GF et al. [Clinical course and treatment of biliary tract lambliasis]. 1967 Vrach Delo pmid:5621415
Borina MIa et al. [Substantiation for antibacterial therapy in acute renal insufficiency under conditions of peritoneal dialysis]. 1969 Vrach Delo pmid:5369651
Kozlov VG [Changes in the organs following the use of sulfadimezin, penicillin and erythromycin in staphylococcal pneumonia. (An experimental histological study)]. 1965 Vrach Delo pmid:5870996
Chernomordik AB [Some problems in using erythromycin, oleandomycin and oletetrin]. 1966 Vrach Delo pmid:5990042
Bass TM [An experimental study of oletetrin]. 1966 Vrach Delo pmid:5990706
Migovan NK [Antibiotic therapy of patients with chronic cholecystitis]. 1969 Vrach Delo pmid:4898166
Nance SJ et al. Erythromycin-induced immune hemolytic anemia. 1988 Vox Sang. pmid:3218168
Butkevich OM [Modern methods of treating septic endocarditis (review of the literature)]. 1969 Oct-Dec Vopr Revm pmid:4314365
Lupanova RI [Erythromycin treatment of children with Botkin's disease with a lesion of the biliary tracts]. 1973 Vopr Okhr Materin Det pmid:4785388
Solov'ev VN and Berezhinskaia VV [Side effects of antibiotic therapy (review of the literature)]. 1974 Vopr Okhr Materin Det pmid:4370853
VERESHCHAGIN Ia [USE OF MONOMYCIN IN ACUTE INTESTINAL INFECTIONS AND STAPHYLOCOCCAL DISEASES IN CHILDREN]. 1964 Vopr Okhr Materin Det pmid:14158842
Buniatova IM et al. [Transplacental passage of erythromycin base]. 1971 Vopr Okhr Materin Det pmid:5142494
Belousova MA et al. [Use of antibacterial therapy in the treatment of inflammatory diseases of the biliary system in children]. 1975 Vopr Okhr Materin Det pmid:1224557
Buniatova IM [Placental permeability for erythromycin ascorbinate in animals previously sensitized with homologous placental protein]. 1973 Vopr Okhr Materin Det pmid:4802732
Imshenetskaia VF [Antibiotics and their use in neurosurgery]. 1966 Mar-Apr Vopr Neirokhir pmid:4873534
Podkolzin IuN [On the epileptogenicity of various antibiotics during their cisternal introduction and topical application to the cerebral cortex (experimental study)]. 1966 Nov-Dec Vopr Neirokhir pmid:6014990
Ivashkin VT et al. [The epidemiological, clinical, diagnostic and treatment aspects of Legionella infection]. 1992 Voen Med Zh pmid:1448947
Hsieh PF et al. The Klebsiella pneumoniae YfgL (BamB) lipoprotein contributes to outer membrane protein biogenesis, type-1 fimbriae expression, anti-phagocytosis, and in vivo virulence. 2016 Virulence pmid:27029012
Novick R Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. 1967 Virology pmid:4227577
Owens RA and Bruening G The pattern of amino acid incorporation into two cowpea mosaic virus proteins in the presence of ribosome-specific protein synthesis inhibitors. 1975 Virology pmid:124497
Inoue M et al. Integration of the erythromycin (ero) resistance gene of a staphylococcal plasmid into S1ppen.ion phage. 1976 Virology pmid:134503
Kreft A et al. JAK2-V617F-mutated myeloproliferative neoplasms reveal different allele burden within hematopoietic cell lineages: a microdissection study of bone marrow trephine biopsies. 2011 Virchows Arch. pmid:22006129
DUGAS M [Erythromycin]. 1954 Vie Med pmid:13179453
MASPETIOL R et al. [The propionic ester of erythromycin in ORL]. 1961 Vie Med pmid:14470873
Kovaleva NP [Susceptibility to antibiotics of Staphylococcus and Bact. coli]. 1973 Veterinariia pmid:4618399
Saryev GA et al. [Erythromycin in abortion of the sheep caused by Chlamydia]. 1977 Veterinariia pmid:595362
SimetskiÄ­ OA [Erythromycin in the treatment of cows with subclinical mastitis]. 1965 Veterinariia pmid:5895871
Parikov VA et al. [Effectiveness of antimastitis preparations]. 1976 Veterinariia pmid:1014354
Bajwa NS et al. Pharmacokinetic profile of erythromycin after intramammary administration in lactating dairy cows with specific mastitis. 2007 Vet. Res. Commun. pmid:17225083
Villar D et al. Novobiocin inhibits both UDP-glucuronosyltransferase and cytochrome P450-mediated enzyme activities in pig liver microsomes. 1998 Vet. Res. Commun. pmid:9810637
Carletti M et al. In vitro formation of metabolic-intermediate cytochrome P450 complexes in rabbit liver microsomes by tiamulin and various macrolides. 2003 Jul-Aug Vet. Res. pmid:12911857
Bertschinger HU Antibiotic resistance. 1989 Vet. Rec. pmid:2919499
Moore JE et al. Erythromycin-resistant thermophilic Campylobacter species isolated from pigs. 1996 Vet. Rec. pmid:8730692
Kelmer G et al. Evaluation of indwelling intravenous catheters for the regional perfusion of the limbs of horses. 2009 Vet. Rec. pmid:19855112
Boyer PJ Outbreak of clinical mastitis in dairy cows following 'blitz' therapy. 1997 Vet. Rec. pmid:9253837
Bodetti TJ et al. Evaluation of tetracycline, erythromycin, penicillin and streptomycin for decontaminating koala semen contaminated in vitro with chlamydiae. 2003 Vet. Rec. pmid:14640326